Medical meetings
Our success as a next-generation BioPharma company will be measured by the difference we can make in the lives of patients facing serious disease. Members of the press may learn more about our company, our philanthropy and our focus on innovative medicines by viewing these resources.
Previous congresses
Our data at the 2022 American Society of Hematology (ASH) Annual Meeting reinforced our commitment to transforming the lives of patients with blood cancers and disorders through science. We shared data and research across a broad range of hematologic diseases, including multiple myeloma, lymphomas, leukemias and other blood disorders.